Celleron Therapeutics
An innovative oncology healthcare company
The future of cancer therapy lies in the ability to target new medicines to responsive tumours. Celleron Therapeutics is dedicated to
the goal of developing novel targeted cancer medicines to treat stratified patient groups. The company has a portfolio of unique cancer therapies
underpinned by a proprietary biomarker technology. All of which are the result of many years experience in cancer research, drug development and
clinical practice.
> Read more
Commercially attractive partnerships
World-class commercialization and development partners required
A unique portfolio of oncology products and technologies for investment.
